Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | Dyne Therapeutics, Inc. | Incerti Carlo
(Director) |
S | Common Stock | D | 16500 | $28.73 - $28.73 | $474,045 |
| 2024-11-18 | Dyne Therapeutics, Inc. | Incerti Carlo
(Director) |
M | Common Stock | A | 16500 | $8.69 - $8.69 | $143,385 |
| 2024-11-14 | Dyne Therapeutics, Inc. | Rhodes Jason P
(Director) |
S | Common Stock | D | 782 | $33.10 - $33.10 | $25,883 |
| 2024-11-18 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 2735 | $28.20 - $28.20 | $77,127 |
| 2024-11-18 | Dyne Therapeutics, Inc. | Beskrovnaya Oxana
(Chief Scientific Officer) |
S | Common Stock | D | 2856 | $28.20 - $28.20 | $80,539 |
| 2024-10-18 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
S | Common Stock | D | 13535 | $35.06 - $35.16 | $475,878 |
| 2024-10-16 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
S | Common Stock | D | 36684 | $35.17 - $35.35 | $1,294,436 |
| 2024-09-16 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
S | Common Stock | D | 4592 | $35.04 - $35.13 | $161,197 |
| 2024-09-06 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 126074 | $32.14 - $32.63 | $4,052,851 |
| 2024-09-06 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
M | Common Stock | A | 116478 | $5.54 - $19.00 | $1,463,374 |
| 2024-09-05 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
S | Common Stock | D | 1577 | $35.03 - $35.03 | $55,242 |
| 2024-08-22 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
S | Common Stock | D | 180409 | $45.82 - $46.97 | $8,302,087 |
| 2024-08-19 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 2752 | $45.01 - $46.00 | $124,174 |
| 2024-08-19 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 2705 | $45.01 - $46.00 | $122,054 |
| 2024-08-19 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 2321 | $45.01 - $46.00 | $104,726 |
| 2024-08-19 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 2910 | $45.01 - $46.00 | $131,303 |
| 2024-08-19 | Dyne Therapeutics, Inc. | Beskrovnaya Oxana
(Chief Scientific Officer) |
S | Common Stock | D | 2636 | $45.01 - $46.00 | $118,939 |
| 2024-06-21 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 39950 | $35.01 - $35.33 | $1,401,900 |
| 2024-06-21 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
M | Common Stock | A | 39950 | $5.54 - $5.54 | $221,322 |
| 2024-06-12 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 40000 | $33.17 - $33.70 | $1,334,200 |
| 2024-06-12 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
M | Common Stock | A | 40000 | $5.54 - $5.54 | $221,600 |
| 2024-06-11 | Dyne Therapeutics, Inc. | Beskrovnaya Oxana
(Chief Scientific Officer) |
S | Common Stock | D | 2136 | $31.34 - $31.34 | $66,942 |
| 2024-06-11 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 2636 | $31.27 - $31.27 | $82,427 |
| 2024-06-10 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 85270 | $30.24 - $31.23 | $2,583,781 |
| 2024-06-10 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
M | Common Stock | A | 80000 | $5.54 - $5.54 | $443,200 |
| 2024-06-11 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 1823 | $31.34 - $31.34 | $57,132 |
| 2024-06-10 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 2921 | $30.23 - $31.34 | $89,778 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |